Company intelligence / Profile preview

Acolad

Paris, France

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Acolad is a leading global provider of translation, localization, and content services with a dedicated division for life sciences, offering certified language solutions to pharmaceutical, biotech, medical device, and clinical research organizations. The company manages content throughout the product development lifecycle, specializing in regulatory-compliant translations and leveraging both human expertise and advanced technologies, including AI[1][2][6][7][8][10].

Industry: Consulting

Partnerships

Clinical Research Organizations (CROs) - unnamedGlobal pharmaceutical companies - unnamedMedical device manufacturers - unnamed

Beyond the preview

Go deeper on Acolad.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acolad.

Explore the full profile